NFKB1 and lung carcinoma: Two cardamonin analogs, 4,4′-dihydroxylchalcone, 17, and 4,4′-dihydroxy-2′-methoxychalcone, 18 (Figure 6), were found to suppress the activation of NF-κB pathway in lung cancer cells.